| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Ryan D. Maynard | Director | Nov 12, 2024 | Sale | $10.06 | 50,000 | 503,000 | 7,500 | Nov 14, 2024, 05:00 PM | |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Ryan D. Maynard | Director | Nov 12, 2024 | Option/RSU Exercise | $7.45 | 50,000 | 372,500 | 57,500 | Nov 14, 2024, 05:00 PM | |
| CARA | Cara Therapeutics, Inc. | Ryan D. Maynard | CHIEF FINANCIAL OFFICER | Feb 08, 2023 | Sale | $0.53 | 5,488 | 2,909 | 8,012 | Feb 12, 2024, 05:15 PM | |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Ryan D. Maynard | Director | May 31, 2022 | Buy | $6.74 | 7,500 | 50,587 | 7,500 | Jun 02, 2022, 08:02 PM | |
| RIGL | RIGEL PHARMACEUTICALS INC | Ryan D. Maynard | EVP & CFO | Nov 03, 2017 | Option/RSU Exercise | $2.14 | 100,000 | 214,000 | 100,000 | Nov 07, 2017, 09:07 PM | |
| RIGL | RIGEL PHARMACEUTICALS INC | Ryan D. Maynard | EVP & CFO | Nov 03, 2017 | Sale | $3.90 | 100,000 | 390,000 | 0 | Nov 07, 2017, 09:07 PM | |
| RIGL | RIGEL PHARMACEUTICALS INC | Ryan D. Maynard | EVP & CFO | Sep 12, 2012 | Option/RSU Exercise | $6.49 | 23,302 | 151,230 | 23,302 | Sep 14, 2012, 07:57 PM | |
| RIGL | RIGEL PHARMACEUTICALS INC | Ryan D. Maynard | EVP & CFO | Sep 12, 2012 | Sale | $10.67 | 23,302 | 248,560 | 0 | Sep 14, 2012, 07:57 PM | |
| RIGL | RIGEL PHARMACEUTICALS INC | Ryan D. Maynard | EVP & CFO | Sep 07, 2012 | Option/RSU Exercise | $6.49 | 23,302 | 151,230 | 23,302 | Sep 14, 2012, 06:19 PM | |
| RIGL | RIGEL PHARMACEUTICALS INC | Ryan D. Maynard | EVP & CFO | Sep 07, 2012 | Sale | $10.67 | 23,302 | 248,560 | 0 | Sep 14, 2012, 06:19 PM | |
| RIGL | RIGEL PHARMACEUTICALS INC | Ryan D. Maynard | EVP & CFO | Sep 10, 2012 | Sale | $10.52 | 17,586 | 184,927 | 0 | Sep 11, 2012, 06:07 PM | |
| RIGL | RIGEL PHARMACEUTICALS INC | Ryan D. Maynard | EVP & CFO | Sep 07, 2012 | Option/RSU Exercise | $6.49 | 34,112 | 221,387 | 34,112 | Sep 11, 2012, 06:07 PM | |
| RIGL | RIGEL PHARMACEUTICALS INC | Ryan D. Maynard | EVP & CFO | Sep 07, 2012 | Sale | $10.55 | 34,112 | 359,960 | 0 | Sep 11, 2012, 06:07 PM | |
| RIGL | RIGEL PHARMACEUTICALS INC | Ryan D. Maynard | EVP & CFO | Sep 10, 2012 | Option/RSU Exercise | $6.49 | 17,586 | 114,133 | 17,586 | Sep 11, 2012, 06:07 PM | |
| RIGL | RIGEL PHARMACEUTICALS INC | Ryan D. Maynard | EVP & CFO | Aug 07, 2012 | Option/RSU Exercise | $6.49 | 1,700 | 11,033 | 1,700 | Aug 09, 2012, 05:39 PM | |
| RIGL | RIGEL PHARMACEUTICALS INC | Ryan D. Maynard | EVP & CFO | Aug 07, 2012 | Sale | $10.61 | 1,700 | 18,041 | 1,000 | Aug 09, 2012, 05:39 PM |
